Innovent Biologics Inc. (IVBXF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Innovent Biologics Inc.

    OTC: IVBXF · Real-Time Price · USD
    12.72
    0.34 (2.75%)
    At close: Oct 03, 2025, 1:56 PM
    12.50
    -1.73%
    After-hours: Oct 02, 2025, 12:07 PM EDT

    Innovent Biologics Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 5.95B 5.47B 3.95B 3.5B 2.7B 2.32B 2.24B 2.33B 1.94B
    Cost of Revenue
    		 1.35B 1.32B 1.09B 1.03B 781.76M 673.38M 708.38M 667.74M 556.68M
    Gross Profit
    		 4.6B 4.15B 2.86B 2.48B 1.92B 1.64B 1.53B 1.66B 1.39B
    Operating Income
    		 773.55M -15.19M -740.69M -960.46M -718.85M -1.67B -1.45B -1.72B -981.35M
    Interest Income
    		 n/a n/a n/a 402.55M 50.29M 132.41M n/a 142.8M n/a
    Pretax Income
    		 897.12M 313.96M -392.58M -888.3M -256.11M -1.17B -998.91M -1.64B -1B
    Net Income
    		 834.32M 297.99M -392.62M -888.76M -139.15M -1.23B -950.47M -1.73B -1B
    Selling & General & Admin
    		 2.82B 2.89B 2.2B 2.14B 1.72B 1.62B 1.81B 2.03B 1.39B
    Research & Development
    		 1.01B 1.28B 1.4B 1.3B 922.82M 1.7B 1.17B 1.35B 974.32M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 3.83B 4.17B 3.6B 3.44B 2.13B 2.95B 2.49B 3.41B 2.36B
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a 44.57M 112.51M 27.1M
    Selling & Marketing Expenses
    		 2.38B 2.47B 1.88B 1.75B 1.35B 1.19B 1.4B 1.54B 1.08B
    Cost & Expenses
    		 5.18B 5.48B 4.69B 4.46B 2.91B 3.62B 3.19B 4.08B 2.92B
    Income Tax Expense
    		 62.8M 15.97M 35K 462K 116.96M 57.24M 48.44M 86.89M 152K
    Shares Outstanding (Basic)
    		 1.7B 1.67B 1.62B 1.58B 1.54B 1.52B 1.46B 1.45B 1.45B
    Shares Outstanding (Diluted)
    		 1.69B 1.63B 1.62B 1.58B 1.54B 1.52B 1.47B 1.46B 1.45B
    EPS (Basic)
    		 0.51 0.18 -0.24 -0.56 -0.09 -0.82 -0.64 -1.18 -0.7
    EPS (Diluted)
    		 0.49 0.18 -0.24 -0.56 -0.09 -0.82 -0.64 -1.18 -0.7
    EBITDA
    		 1.03B -231.41M -248.86M -741.75M -546.59M -1.53B -1.34B -1.63B -903.65M
    EBIT
    		 773.55M -323.55M -432.32M -845.1M -718.85M -1.67B -1.45B -1.72B -981.35M
    Depreciation & Amortization
    		 256.03M 92.14M 183.46M 103.34M 172.25M 139.89M 105.2M 87.7M 77.7M

    Add to Watchlist